510(k) device
Quantra QStat Cartridge
Hemosonics, LLC · Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties (QFR, Class II) · First FDA decision Aug 25, 2025, newest Aug 25, 2025Anemia, clotting and blood disordersSurgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Quantra QStat Cartridge"
MAUDE reports
0
Brand "Quantra QStat Cartridge", since 2015
PubMed studies
0
Mentioning "Quantra QStat Cartridge"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Quantra QStat Cartridge
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Quantra QStat Cartridge510(k)
K251404 · Decided Aug 25, 2025 · 111 days after receipt
Device type: Coagulation System For The Measurement Of Whole Blood Viscoelastic Properties (QFR) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Quantra QStat Cartridge", any status and sponsor, newest update first.
HemoSonics LLCNot on our public-company list
NCT05875987 · 50 participants · Start Jun 1, 2023 · Primary completion Mar 31, 2024
Device: Quantra System · For: Blood Loss Massive; Post Operative Hemorrhage
Sites: Durham, North Carolina
- Quantra QStat Sample Type ComparisonCompleted
HemoSonics LLCNot on our public-company list
NCT06025708 · 25 participants · Start Sep 11, 2023 · Primary completion Jan 5, 2024
Device: Diagnostic Test: Quantra QStat Cartridge · For: Coagulation Defect; Bleeding
Sites: Columbus, Ohio
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Quantra QStat Cartridge", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QFR
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Quantra QStat Cartridge"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QFR.
- Quantra Hemostasis AnalyzerHemosonics, LLC · De Novo 2023
- QStat CartridgeHemosonics, LLC · 510(k) 2024
- Quantra QPlus SystemHemosonics, LLC · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.